Houlihan Lokey price target raised to $206 from $168 at Goldman Sachs

Goldman Sachs raised the firm’s price target on Houlihan Lokey (HLI) to $206 from $168 and keeps a Buy rating on the shares. Goldman Sachs remains constructive on Houlihan Lokey due to its structural, through-the-cycle growth potential and robust track record of successful organic and inorganic investment, and says the company appears set to gain further momentum in corporate finance in 2025, the analyst tells investors in a research note. The firm sees Houlihan-Lokey continuing to supplement growth through a proven track record of acquisitions.